CRP and adult-onset Still disease: Similarly, the time delay between AOSD onset and the start of ANK did not represent a predictor of treatment outcome considered as ANK effectiveness, complete AOSD control according to the systemic score, achievement of a DAS28-CRP <2.6 and complete resolution of inflammatory markers.